focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrincess Priv E Regulatory News (PEY)

Share Price Information for Princess Priv E (PEY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.35
Bid: 11.40
Ask: 11.45
Change: 0.00 (0.00%)
Spread: 0.05 (0.439%)
Open: 11.45
High: 11.45
Low: 11.25
Prev. Close: 11.35
PEY Live PriceLast checked at -
Princess Private Equity Holding is an Investment Trust

To provide Shareholders with long-term capital growth and attractive dividend yield, through investment in a diversified portfolio of private equity and private debt investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV increases by 1.8%

25 Oct 2017 07:00

RNS Number : 5095U
Princess Private Equity Holding Ltd
25 October 2017
 

News Release

Guernsey, 25 October 2017

 

NAV increases by 1.8%

 

· Princess Private Equity Holding Limited's ("Princess") net asset value increased by 1.8% to EUR 10.90 per share

· Currency movements (0.1%) and overall portfolio developments (2.0%) were positive

· Princess received distributions of EUR 6.9 million and invested EUR 10.0 million over the reporting period

 

The direct investments VAT Group AG ("VAT"), Trimco and Dynacast were amongst the largest contributors to NAV growth during September. VAT, the global leader in the production of high-end vacuum valves continued the strong share price performance seen since its IPO in April 2016. Trimco, a leading supplier of garment labels, tags and trimming products, was written up as a result of continued financial and operational strength across the group. EBITDA growth was driven by increased sales volume at Clotex Group and Labelon, while Trimco's EBITDA margin benefitted from a greater volume of higher profit-margin products sold, and savings in marketing and rental expenses following the integration of A-Tex. Partners Group continues to work in close partnership with Trimco's management to realize cross-selling synergies. Dynacast was written up on the back of strong financial performance. The company's EBITDA increased driven by the acquisition of Signicast in March 2017 and strong growth in the European industrial electronics market and automotive industries. Partners Group continues to assist Dynacast with the integration of Signicast and identification of further acquisition targets.

 

Princess received distributions of EUR 6.9 million during the month, including EUR 1.3 million from the partial sale of shares in Food company 1, a foodservice distributor based in the US and listed on the New York Stock Exchange. The remaining distributions of EUR 5.6 million came predominantly from Princess' mature legacy fund portfolio. During the month, Princess also participated in a placing of shares in VAT. The proceeds of EUR 29.6 million were received shortly after month-end and will be reflected in the company's net liquidity position in the company's October month-end report. Following the transaction, funds managed and/or advised by Partners Group continue to hold 13.1% of the company's share capital.

 

Princess invested a total of EUR 10.0 million during the month, of which EUR 6.2 million was allocated to STADA Arzneimittel AG, a German-based manufacturer of generic pharmaceuticals and branded over-the-counter ("OTC") products. Partners Group invested alongside Cinven and Bain Capital. The company is currently one of the largest within the European generics sector. Partners Group believes that the asset represents an attractive investment opportunity with potential to increase top-line growth and improve its below market profitability. Princess made an add-on investment of EUR 1.3 million in Partners Group Pacific Restaurant Holdings in support of the company's buy-and-build strategy. To-date Princess has invested EUR 6.2 million in the company, a leading franchisee of Taco Bell and Buffalo Wild Wings restaurants in the US. Since Partners Group's initial investment in October 2015, the company has made seven add-on acquisitions. Princess also added to its debt investment in Caffè Nero, a founder-owned European coffee house chain. Princess acquired EUR 2.3 million of mezzanine debt in a secondary purchase, increasing the amount invested to EUR 9.9 million. Caffè Nero operates more than 800 stores globally, the majority of which are located in the UK.

 

Princess will hold its quarterly investor conference call on 8 November 2017 10:00 AM GMT and will provide a detailed update on the recent portfolio developments. Please find the dial in details on the company's webpage.

 

Further information is available in the monthly report which can be accessed via: http://www.princess-privateequity.net/financialreports.

 

Ends.

 

About Princess

Princess is an investment holding company founded in 1999 and domiciled in Guernsey. It invests, inter alia, in private equity and private debt investments. Princess is advised in its investment activities by Partners Group, a global private markets investment management firm with EUR 58 billion in investment programs under management in private equity, private debt, private real estate and private infrastructure. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote). Further information: www.princess-privateequity.net.

 

Contacts

Princess Private Equity Holding Limited:

princess@partnersgroup.com

www.princess-privateequity.net

 

Registered Number: 35241

 

LEI: 54930038LU8RDPFFVJ57

 

Investor relations contact

George Crowe

Phone: +44 (0)20 7575 2771

Email: george.crowe@partnersgroup.com

 

Media relations contact

Jenny Blinch

Phone: +41 41 784 65 26

Email: jenny.blinch@partnersgroup.com

www.partnersgroup.com

 

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

 

This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of Princess' website nor the contents of any website accessible from hyperlinks on Princess' website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUSRNRBVARUAA
Date   Source Headline
23rd Apr 20217:00 amRNSNotice of Annual General Meeting
15th Apr 20217:00 amRNSDeclaration of first interim dividend for FY 2021
1st Apr 20217:00 amRNSCompliance with Model Code
1st Apr 20217:00 amRNSTotal Voting Rights
31st Mar 202111:20 amRNSPartners Group to sell GlobalLogic
31st Mar 20217:32 amRNSDiscussions to exit investment in Cerba HealthCare
24th Mar 20217:00 amRNSNAV increases by 0.9% in February
22nd Mar 20217:00 amRNSPrincess publishes Annual Report 2020
1st Mar 20217:00 amRNSTotal Voting Rights
24th Feb 20217:00 amRNSNAV increases by 0.1% in January
16th Feb 20217:00 amRNSQ4 2020 quarterly results presentation
10th Feb 20217:00 amRNSQ4 2020 quarterly results presentation
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSNAV increases by 3.1% in December
4th Jan 20217:00 amRNSCompliance with Model Code
4th Jan 20217:00 amRNSTotal Voting Rights
23rd Dec 20207:00 amRNSNAV increases by 3.1% in November
1st Dec 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSPrincess publishes October NAV
19th Nov 20202:56 pmRNSDividend Declaration
16th Nov 20207:00 amRNSQ3 2020 quarterly results presentation
4th Nov 20207:00 amRNSQ3 2020 quarterly results presentation
2nd Nov 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNAV increases by 3.8% in September
1st Oct 20207:00 amRNSCompliance with Model Code
1st Oct 20207:00 amRNSTotal Voting Rights
25th Sep 20207:00 amRNSNAV increases by 3.1% in August
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSNAV increases by 2.3% in July
25th Aug 20207:00 amRNSPartners Group to sell PCI Pharma Services
17th Aug 20207:00 amRNSPrincess publishes Half-Year Report 2020
7th Aug 20207:00 amRNSPrincess Q2 2020 Results Presentation
3rd Aug 20207:00 amRNSTotal Voting Rights
28th Jul 20207:00 amRNSNew Investment Management Agreement
24th Jul 20207:00 amRNSNAV increases by 2.9% in June
10th Jul 20204:45 pmRNSRevision to Dividend Payment Date
1st Jul 20207:00 amRNSCompliance with Model Code
1st Jul 20207:00 amRNSTotal Voting Rights
25th Jun 20207:00 amRNSNAV increases by 3.0% in May
23rd Jun 20207:00 amRNSDividend Declaration
11th Jun 20207:00 amRNSExit of Action closed
5th Jun 20207:00 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSTotal Voting Rights
27th May 20203:00 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSNAV increases by 5.6% in April
22nd May 20207:30 amRNSHolding(s) in Company
12th May 20207:00 amRNSPrincess Q1 2020 Results Presentation
6th May 20201:52 pmRNSResult of Annual General Meeting
1st May 20207:00 amRNSPrincess Statement of COVID-19 & dividend guidance
1st May 20207:00 amRNSPrincess publishes March NAV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.